Patents by Inventor Yangping LV

Yangping LV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Porcine epidemic diarrhea virus S protein and subunit vaccine thereof as well as method for preparing subunit vaccine and application thereof
    Patent number: 10925959
    Abstract: The disclosure discloses a porcine epidemic diarrhea virus S protein and a subunit vaccine thereof as well as a method for preparing the subunit vaccine and application thereof. The vaccine contains 30˜220 ?g of a recombinant porcine epidemic diarrhea virus S protein and a pharmaceutically acceptable ISA 201 VG adjuvant. A method for preparing the subunit vaccine comprises the following steps: (1) cloning the recombinant porcine epidemic diarrhea virus S protein; (2) expressing and purifying the recombinant porcine epidemic diarrhea virus S protein; (3) preparing the recombinant porcine epidemic diarrhea virus S protein prepared in (2) into a water phase; (4) emulsifying the water phase and the ISA 201 VG adjuvant in a volume ratio of 46:54 to obtain a vaccine. The vaccine is high in safety, good in immunogenicity, stable in batches, low in production cost and strong in immunogenicity.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: February 23, 2021
    Inventors: Hong Qian, Youqiang Wu, Guanglin Bian, Qiang Zhang, Yulan Xu, Zhijun Bai, Sufang Wu, Ying Che, Yangping Lv, Yinhe Zha
  • PORCINE EPIDEMIC DIARRHEA VIRUS S PROTEIN AND SUBUNIT VACCINE THEREOF AS WELL AS METHOD FOR PREPARING SUBUNIT VACCINE AND APPLICATION THEREOF
    Publication number: 20200188508
    Abstract: The disclosure discloses a porcine epidemic diarrhea virus S protein and a subunit vaccine thereof as well as a method for preparing the subunit vaccine and application thereof. The vaccine contains 30˜220 ?g of a recombinant porcine epidemic diarrhea virus S protein and a pharmaceutically acceptable ISA 201 VG adjuvant. A method for preparing the subunit vaccine comprises the following steps: (1) cloning the recombinant porcine epidemic diarrhea virus S protein; (2) expressing and purifying the recombinant porcine epidemic diarrhea virus S protein; (3) preparing the recombinant porcine epidemic diarrhea virus S protein prepared in (2) into a water phase; (4) emulsifying the water phase and the ISA 201 VG adjuvant in a volume ratio of 46:54 to obtain a vaccine. The vaccine is high in safety, good in immunogenicity, stable in batches, low in production cost and strong in immunogenicity.
    Type: Application
    Filed: October 11, 2019
    Publication date: June 18, 2020
    Inventors: Hong QIAN, Youqiang WU, Guanglin BIAN, Qiang ZHANG, Yulan XU, Zhijun BAI, Sufang WU, Ying CHE, Yangping LV, Yinhe ZHA